CSIMarket
 


Cryoport inc   (CYRX)
Other Ticker:  
 
 

Cryoport Inc Accounts Receivables Turnover Ratio from the forth quarter 2023 to the forth quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Cryoport Inc 's ability to collect accounts receivable sequentially worsen to 5.38, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Average collection period, for Cryoport Inc 's accounts receivable remained unchanged at 68 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 181 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1508, from overall ranking in the third quarter 2023 at 1735.

What is Receivable Turnover Ratio?
What is Cryoport Inc Selling?


What is Receivable Turnover Ratio?




CYRX Receivables Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Receivable Change -4.07 % -4.04 % -1.88 % 27.17 % 11.28 %
Y / Y Revenue Change -5.13 % -7.12 % -11.12 % 20.1 % 6.94 %
Receivable Turnover Ratio (TTM) 5.38 5.4 5.44 5.58 5.65
CYRX's Total Ranking # 1508 # 1735 # 2893 # 1052 # 1764
Average receivable collection period 68 68 67 65 65
Seq. Receivable Change -1.29 % -1.04 % -5.48 % 3.91 % -1.26 %
Seq. Revenue Change 1.96 % -1.52 % -9.23 % 4.07 % -0.18 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 54
Healthcare Sector # 182
Overall Market # 1508

Receivable Turnover Ratio Statistics
High Average Low
8.29 6.42 5.38
(March 31, 2015)   (Dec 31 2023)






Financial Statements
Cryoport Inc 's Accounts Receivable $ 42 Millions Visit CYRX's Balance sheet
Cryoport Inc 's Sales TTM $ 233 Millions Visit CYRX's Income Statement
Where are CYRX's Sales coming from? Visit CYRX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CYRX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for CYRX's Competitors
Receivables Turnover Ratio for CYRX's Suppliers
Accounts Receivables Turnover Ratio for CYRX's Customers

You may also want to know
CYRX's Growth Rates CYRX's Roa CYRX's Inventory Turnover Ratio CYRX's Dividend Comparisons
CYRX's Profitability Ratios CYRX's Roi CYRX's Asset Turnover Ratio CYRX's Dividend Growth
CYRX's Valuation Ratios CYRX's Roe CYRX's Financial Strength Ratios CYRX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Receivable at quarter ending Dec 31 2023
Owens and Minor inc  15.24 $ 10,333.161  Millions$ 677.813  Millions
Neuroone Medical Technologies Corporation  14.87 $ 2.816  Millions$ 0.189  Millions
Chemed Corporation  14.52 $ 2,264.417  Millions$ 155.918  Millions
Icu Medical Inc  14.46 $ 2,259.126  Millions$ 156.262  Millions
Patterson Companies Inc   14.11 $ 6,565.239  Millions$ 465.318  Millions
Corcept Therapeutics Inc  13.70 $ 482.375  Millions$ 35.215  Millions
Theralink Technologies Inc   13.67 $ 0.511  Millions$ 0.037  Millions
Protalix Biotherapeutics inc   13.39 $ 65.494  Millions$ 4.890  Millions
Exact Sciences Corporation  13.25 $ 2,532.479  Millions$ 191.179  Millions
Utah Medical Products Inc  12.39 $ 50.658  Millions$ 4.088  Millions
Teladoc Health Inc   12.18 $ 2,602.415  Millions$ 213.613  Millions
Caribou Biosciences Inc   12.12 $ 34.477  Millions$ 2.844  Millions
Siga Technologies Inc  11.78 $ 139.917  Millions$ 11.881  Millions
Integrated Biopharma Inc  11.42 $ 48.833  Millions$ 4.275  Millions
Option Care Health Inc   11.09 $ 4,302.223  Millions$ 388.081  Millions
National Research Corporation  11.05 $ 148.580  Millions$ 13.445  Millions
National Healthcare Corp  10.98 $ 1,141.544  Millions$ 104.011  Millions
Revance Therapeutics Inc   10.95 $ 234.040  Millions$ 21.377  Millions
Biontech Se  10.68 $ 4,277.280  Millions$ 400.624  Millions
Arrowhead Pharmaceuticals Inc   10.29 $ 181.740  Millions$ 17.670  Millions
Viemed Healthcare Inc   10.22 $ 183.008  Millions$ 17.905  Millions
Sophia Genetics Sa  10.15 $ 61.913  Millions$ 6.100  Millions
Lumos Pharma Inc   10.07 $ 2.051  Millions$ 0.204  Millions
Semler Scientific Inc   9.93 $ 68.184  Millions$ 6.867  Millions
United Therapeutics Corporation  9.85 $ 2,327.500  Millions$ 236.175  Millions
Xoma Corporation  9.74 $ 4.758  Millions$ 0.489  Millions
Eton Pharmaceuticals Inc   9.66 $ 31.061  Millions$ 3.216  Millions
Procyon Corporation  9.64 $ 4.700  Millions$ 0.488  Millions
Innovative Eyewear Inc   9.62 $ 1.152  Millions$ 0.120  Millions
The Pennant Group Inc   9.54 $ 544.891  Millions$ 57.095  Millions

Date modified: 2024-03-13T23:04:03+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com